Davis Todd C
SEC insider (Form 3/4/5 filer). CIK 0001392029. Chief Executive Officer at LIGAND PHARMACEUTICALS INC (LGND) and 2 other issuers. 32 reported Form 4/5 transactions since Sep 2024; latest on Jun 30, 2026. Located in JUPITER, FL.
Companies Davis Todd C has filed insider reports for
- LIGAND PHARMACEUTICALS INC (LGND): Director, Officer, Chief Executive Officer
- Pelthos Therapeutics Inc. (PTHS): Director
- PALVELLA THERAPEUTICS, INC. (PVLA): Director
Davis Todd C
CIK: 0001392029
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (32 total)
- Jun 30, 2026LGND
LIGAND PHARMACEUTICALS INC
OtherDirect132 shares at avg. $160.71$21K - Jun 11, 2026PTHS
Pelthos Therapeutics Inc.
PurchaseDirect35.4K shares at avg. $27.80$986K - Jun 11, 2026PTHS
Pelthos Therapeutics Inc.
PurchaseDirect503 shares at avg. $28.73$14K - Jun 10, 2026PVLA
PALVELLA THERAPEUTICS, INC.
AwardDirectStock Option (Right to Buy)
3K shares- - Mar 2, 2026LGND
LIGAND PHARMACEUTICALS INC
AwardDirect10.5K shares- - Feb 15, 2026LGND
LIGAND PHARMACEUTICALS INC
Tax PaymentDirect2.8K shares at avg. $183.83$516K - Feb 15, 2026LGND
LIGAND PHARMACEUTICALS INC
Tax PaymentDirect2K shares at avg. $183.83$375K - Feb 15, 2026LGND
LIGAND PHARMACEUTICALS INC
Tax PaymentDirect4.3K shares at avg. $183.83$782K - Feb 14, 2026LGND
LIGAND PHARMACEUTICALS INC
Tax PaymentDirect15.6K shares at avg. $183.83$2.9M - Feb 14, 2026LGND
LIGAND PHARMACEUTICALS INC
Tax PaymentDirect8.2K shares at avg. $183.83$1.5M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 30, 2026 |  LGND LIGAND PHARMACEUTICALS INC | Other | 132 | $160.71 | $21,214 | Direct |
| Jun 11, 2026 |  PTHS Pelthos Therapeutics Inc. | Purchase | 35,445 | $27.80 | $985,534 | Direct |
| Jun 11, 2026 | PTHS Pelthos Therapeutics Inc. | Purchase | 503 | $28.73 | $14,449 | Direct |
| Jun 10, 2026 |  PVLA PALVELLA THERAPEUTICS, INC. | Award Stock Option (Right to Buy) | 3,000 | - | - | Direct |
| Mar 2, 2026 | LGND LIGAND PHARMACEUTICALS INC | Award | 10,495 | - | $0 | Direct |
| Feb 15, 2026 | LGND LIGAND PHARMACEUTICALS INC | Tax Payment | 2,805 | $183.83 | $515,643 | Direct |
| Feb 15, 2026 | LGND LIGAND PHARMACEUTICALS INC | Tax Payment | 2,039 | $183.83 | $374,829 | Direct |
| Feb 15, 2026 | LGND LIGAND PHARMACEUTICALS INC | Tax Payment | 4,255 | $183.83 | $782,197 | Direct |
| Feb 14, 2026 | LGND LIGAND PHARMACEUTICALS INC | Tax Payment | 15,600 | $183.83 | $2,867,748 | Direct |
| Feb 14, 2026 | LGND LIGAND PHARMACEUTICALS INC | Tax Payment | 8,178 | $183.83 | $1,503,362 | Direct |
1-10 of 32 transactions